200 related articles for article (PubMed ID: 24390103)
1. A novel mouse xenotransplantation model of EBV-T/NK-LPD and the application of the mouse model.
Imadome K
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(6):433-41. PubMed ID: 24390103
[TBL] [Abstract][Full Text] [Related]
2. Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells.
Imadome K; Yajima M; Arai A; Nakazawa A; Kawano F; Ichikawa S; Shimizu N; Yamamoto N; Morio T; Ohga S; Nakamura H; Ito M; Miura O; Komano J; Fujiwara S
PLoS Pathog; 2011 Oct; 7(10):e1002326. PubMed ID: 22028658
[TBL] [Abstract][Full Text] [Related]
3. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
[TBL] [Abstract][Full Text] [Related]
4. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
[TBL] [Abstract][Full Text] [Related]
5. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
Ohshima K; Kimura H; Yoshino T; Kim CW; Ko YH; Lee SS; Peh SC; Chan JK;
Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
7. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
Kimura H
Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
[TBL] [Abstract][Full Text] [Related]
9. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
Front Pediatr; 2019; 7():183. PubMed ID: 31231620
[TBL] [Abstract][Full Text] [Related]
10. Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection.
Fournier B; Boutboul D; Bruneau J; Miot C; Boulanger C; Malphettes M; Pellier I; Dunogué B; Terrier B; Suarez F; Blanche S; Castelle M; Winter S; Delecluse HJ; Molina T; Picard C; Ehl S; Moshous D; Galicier L; Barlogis V; Fischer A; Neven B; Latour S
J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32812031
[TBL] [Abstract][Full Text] [Related]
11. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.
Cohen JI; Jaffe ES; Dale JK; Pittaluga S; Heslop HE; Rooney CM; Gottschalk S; Bollard CM; Rao VK; Marques A; Burbelo PD; Turk SP; Fulton R; Wayne AS; Little RF; Cairo MS; El-Mallawany NK; Fowler D; Sportes C; Bishop MR; Wilson W; Straus SE
Blood; 2011 Jun; 117(22):5835-49. PubMed ID: 21454450
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous, restricted patterns of Epstein-Barr virus (EBV) latent gene expression in patients with chronic active EBV infection.
Yoshioka M; Ishiguro N; Ishiko H; Ma X; Kikuta H; Kobayashi K
J Gen Virol; 2001 Oct; 82(Pt 10):2385-2392. PubMed ID: 11562532
[TBL] [Abstract][Full Text] [Related]
13. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
Zhang Y; Nagata H; Ikeuchi T; Mukai H; Oyoshi MK; Demachi A; Morio T; Wakiguchi H; Kimura N; Shimizu N; Yamamoto K
Br J Haematol; 2003 Jun; 121(5):805-14. PubMed ID: 12780797
[TBL] [Abstract][Full Text] [Related]
14. [Significance of detecting the EBV-DNA level in peripheral blood mononuclear cells and the EBV-infected cell type in patients with chronic active EBV infection].
Xing Y; Song HM; Wu XY; Wang W; Wei M
Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):495-500. PubMed ID: 22088177
[TBL] [Abstract][Full Text] [Related]
15. [Clinical features and laboratory findings of adult Epstein-Barr virus associated T/NK lymphoproliferative disease].
Zhang Q; Zhang HY; Zhang WL; Zhong FL; Feng J; Meng QX; Yin WH; Nie LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):953-7. PubMed ID: 23998592
[TBL] [Abstract][Full Text] [Related]
16. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
[TBL] [Abstract][Full Text] [Related]
17. Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus.
Islas-Ohlmayer M; Padgett-Thomas A; Domiati-Saad R; Melkus MW; Cravens PD; Martin Mdel P; Netto G; Garcia JV
J Virol; 2004 Dec; 78(24):13891-900. PubMed ID: 15564497
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
19. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
[TBL] [Abstract][Full Text] [Related]
20. EBV in T-/NK-Cell Tumorigenesis.
Kimura H
Adv Exp Med Biol; 2018; 1045():459-475. PubMed ID: 29896680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]